News worth knowing: A Stem Cell Scam Unravels…
By Marc Stecker-Wheelchair Kamikaze—January 30, 2015 As many MS patients are aware, stem cells represent one of the great hopes for vanquishing multiple…
More Encouraging Results From Stem-Cell Transplants
Source: MSDiscovery.org A new study shows good outcomes using a less intense conditioning regimen, suggesting it may be possible to perform…
Stuart Schlossman
Ottawa Hospital leads Canadian clinical trial on stem cell therapy in MS patients
Joanne Schnurr, CTV Ottawa Published Thursday, January 29, 2015 Last Updated Thursday, January 29, 2015 People with Multiple Sclerosis are…
Stuart Schlossman
Early Study Says Stem Cells May Reverse Multiple Sclerosis Disability
By Amy Norton, HealthDay News Small initial trial showed improvement for people with relapsing-remitting MS The stem cell treatment was most…
Stuart Schlossman
Interim Results from a Clinical Trial of Stem Cell Transplantation for Relapsing-Remitting MS
Interim Results from a Clinical Trial of Stem Cell Transplantation for Relapsing-Remitting MS Results from the first three years of…
Stuart Schlossman
Stem cell treatment halts MS progression in 91% of patients
Image: Macrophages accumulating around a lesion caused by MS. Credit: Marvin 101 / Wikimedia Jan 2015 A group of multiple sclerosis…
Stuart Schlossman
MS patient ‘shocked’ by claims about company in stem cell experiment
Linda Friesen says she left her wheelchair behind in India after undergoing experimental therapy CBC News Posted: Jan 16, 2015 A…
Stuart Schlossman
Stem Cell News Alert — City man who ran stem-cell trial for MS patients fabricated THE credentials, overstated results
THANKS to Dana D. – for sending this information;;;;;;;;;;;;;;;;;; By: Melissa Martin and Mary Agnes Welch Posted: 01/13/2015 10:32 PM The hope…
Stuart Schlossman
Experimental MS treatment halts disease ‘in its tracks’
information showing below was provided by Nina F – thank you A Seattle man is among two dozen MS patients…
Stuart Schlossman
‘Immune Reset’ Effective Against MS Short Term
Some 90% of patients with relapsing-remitting multiple sclerosis had no clinical relapses or signs of progression 3 years after receiving…
Stuart Schlossman
